Table 1.
Patient Characteristics by End-Stage Renal Disease Treatment Type, All Years
| Characteristics | Treatment Type | P | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| HD | PD | Transplant | All Groups | HD vs. PD | Dialysis vs. Transplant | |
| Average annual cohort (n) | 670 | 525 | 1100 | |||
| Age group, yrs. (%) | < 0.0001 | < 0.0001 | < 0.0001 | |||
| 0–4 | 5.26 | 22.68 | 9.52 | |||
| 5–9 | 8.20 | 15.79 | 17.48 | |||
| 10–14 | 24.55 | 29.12 | 29.65 | |||
| 15–18 | 61.99 | 32.41 | 43.35 | |||
| Female (%) | 46.28 | 46.00 | 41.75 | < 0.0001 | 0.701 | < 0.0001 |
| Race (%) | < 0.0001 | < 0.0001 | < 0.0001 | |||
| White | 53.72 | 67.36 | 73.68 | |||
| Black | 39.77 | 26.14 | 20.98 | |||
| Other | 6.52 | 6.50 | 5.35 | |||
| Primary cause of ESRD (%) | < 0.0001 | < 0.0001 | < 0.0001 | |||
| Glomerulonephritis | 32.67 | 28.72 | 26.67 | |||
| Congenital/reflux/obstructive | 50.24 | 57.71 | 58.14 | |||
| Other | 9.71 | 7.40 | 9.40 | |||
| Unknown/missing | 7.37 | 6.16 | 5.79 | |||
| Incident (%) | 26.69 | 22.72 | 3.43 | < 0.0001 | < 0.0001 | < 0.0001 |
| Prior transplant (%) | 25.93 | 16.67 | NA | NA | < 0.0001 | NA |
| Wait-listed (%) | 37.09 | 33.82 | NA | NA | < 0.0001 | NA |
| Comorbidity (%) | < 0.0001 | < 0.0001 | < 0.0001 | |||
| None | 59.38 | 67.56 | 72.56 | |||
| ≥ 1 condition | 39.20 | 31.03 | 25.04 | |||
| Missing | 1.43 | 1.40 | 2.39 | |||
| Cause of death* (%) | 0.0013 | 0.121 | 0.0008 | |||
| Cardiovascular | 33.63 | 32.18 | 14.04 | |||
| Infection | 19.22 | 24.52 | 26.32 | |||
| Malignancy | 5.11 | 1.53 | 7.89 | |||
| Missing | 11.71 | 11.88 | 15.79 | |||
| Other | 30.33 | 29.89 | 35.96 | |||
*
During follow-up.
ESRD, end-stage renal disease; HD, hemodialysis; NA, not applicable; PD, peritoneal dialysis.